Annual Operating Expenses
$78.19 M
+$10.60 M+15.68%
December 31, 2023
Summary
- As of March 6, 2025, DSGN annual total operating expenses is $78.19 million, with the most recent change of +$10.60 million (+15.68%) on December 31, 2023.
- During the last 3 years, DSGN annual operating expenses has risen by +$69.86 million (+838.66%).
- DSGN annual operating expenses is now at all-time high.
Performance
DSGN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$16.25 M
+$1.20 M+8.00%
September 30, 2024
Summary
- As of March 6, 2025, DSGN quarterly total operating expenses is $16.25 million, with the most recent change of +$1.20 million (+8.00%) on September 30, 2024.
- Over the past year, DSGN quarterly operating expenses has stayed the same.
- DSGN quarterly operating expenses is now -28.10% below its all-time high of $22.60 million, reached on June 30, 2023.
Performance
DSGN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
DSGN Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.7% | 0.0% |
| 3 y3 years | +838.7% | 0.0% |
| 5 y5 years | +3998.0% | 0.0% |
DSGN Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +118.2% | -28.1% | +46.0% |
| 5 y | 5-year | at high | +3998.0% | -28.1% | +2507.7% |
| alltime | all time | at high | +3998.0% | -28.1% | +2507.7% |
Design Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.25 M(+8.0%) |
| Jun 2024 | - | $15.04 M(+4.5%) |
| Mar 2024 | - | $14.40 M(-4.8%) |
| Dec 2023 | $78.19 M(+15.7%) | $15.12 M(-19.7%) |
| Sep 2023 | - | $18.82 M(-16.7%) |
| Jun 2023 | - | $22.60 M(+4.4%) |
| Mar 2023 | - | $21.65 M(+11.6%) |
| Dec 2022 | $67.59 M | $19.39 M(+1.0%) |
| Sep 2022 | - | $19.19 M(+22.7%) |
| Jun 2022 | - | $15.64 M(+17.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $13.37 M(+20.2%) |
| Dec 2021 | $35.83 M(+330.1%) | $11.13 M(-1.9%) |
| Sep 2021 | - | $11.34 M(+47.5%) |
| Jun 2021 | - | $7.69 M(+35.3%) |
| Mar 2021 | - | $5.68 M(+47.1%) |
| Dec 2020 | $8.33 M(+336.6%) | $3.86 M(+62.0%) |
| Sep 2020 | - | $2.38 M(+62.9%) |
| Jun 2020 | - | $1.46 M(+134.8%) |
| Mar 2020 | - | $623.00 K |
| Dec 2019 | $1.91 M | - |
FAQ
- What is Design Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Design Therapeutics?
- What is Design Therapeutics annual operating expenses year-on-year change?
- What is Design Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Design Therapeutics?
- What is Design Therapeutics quarterly operating expenses year-on-year change?
What is Design Therapeutics annual total operating expenses?
The current annual operating expenses of DSGN is $78.19 M
What is the all time high annual operating expenses for Design Therapeutics?
Design Therapeutics all-time high annual total operating expenses is $78.19 M
What is Design Therapeutics annual operating expenses year-on-year change?
Over the past year, DSGN annual total operating expenses has changed by +$10.60 M (+15.68%)
What is Design Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of DSGN is $16.25 M
What is the all time high quarterly operating expenses for Design Therapeutics?
Design Therapeutics all-time high quarterly total operating expenses is $22.60 M
What is Design Therapeutics quarterly operating expenses year-on-year change?
Over the past year, DSGN quarterly total operating expenses has changed by $0.00 (0.00%)